8-KEarnings & ResultsExhibits & Filings

ALNYLAM PHARMACEUTICALS, INC. 8-K Report, Financial Results (Feb 23, 2023)

Filed February 23, 2023For Securities:ALNY

Summary

Alnylam Pharmaceuticals, Inc. (ALNY) announced its financial results for the fourth quarter and full year ended December 31, 2022, via an 8-K filing on February 23, 2023. The filing primarily serves as a vehicle to furnish the press release containing these results. Investors should note that the information furnished in this Item 2.02 is not considered 'filed' for regulatory purposes, meaning it does not carry the same legal liabilities as traditional filings. However, the press release itself is expected to contain key financial performance indicators and strategic updates relevant to the company's ongoing operations and future outlook. While the 8-K itself does not contain the detailed financial figures, it directs investors to Exhibit 99.1, the press release, for the specific results. Investors are encouraged to review this press release for comprehensive information regarding revenue, profitability, cash position, and any forward-looking guidance or significant operational developments disclosed by Alnylam. This filing is a standard procedure for disseminating earnings information promptly to the market.

Key Highlights

  • 1Alnylam Pharmaceuticals announced Q4 and Full Year 2022 financial results on February 23, 2023.
  • 2The 8-K filing serves to furnish the earnings press release (Exhibit 99.1) containing the detailed results.
  • 3Information provided in Item 2.02 is furnished, not filed, limiting its liability under Section 18 of the Exchange Act.
  • 4Investors should refer to the press release (Exhibit 99.1) for specific financial data and operational updates.
  • 5The filing indicates the company is adhering to standard reporting practices for financial results dissemination.

Frequently Asked Questions

The specific financial results, including revenue, profitability, and other key metrics for the quarter and year ended December 31, 2022, are detailed in the press release furnished as Exhibit 99.1 to this Form 8-K filing.

When information is 'furnished' (as opposed to 'filed'), it means it is provided to the SEC for public dissemination but does not carry the same legal liability under Section 18 of the Securities Exchange Act of 1934, as amended. It is generally not subject to the same level of scrutiny regarding accuracy and completeness as 'filed' information.

The 8-K filing itself primarily announces the release of financial results. Any new business developments, strategic updates, or forward-looking guidance would be contained within the press release (Exhibit 99.1) that is furnished with this filing.